{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:24:37Z","timestamp":1792034677066,"version":"4.4.0"},"reference-count":61,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Psychedelic Medicine"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Recent studies suggest that one to two administrations of psilocybin have acute antidepressant effects for people with major depressive disorder. These data on psilocybin have generated considerable enthusiasm, but little empirical attention has been paid to the therapy that adjoins psilocybin treatment (psychedelic-assisted therapy, or PAT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this study, we present the initial protocol and plans to empirically test the psychosocial therapy that adjoins psilocybin treatment with the goal of optimizing this therapeutic approach for adults with major depressive disorder. The psychotherapy is based on the principles of cognitive-behavioral therapy (CBT), an evidence-based treatment for major depressive disorder. Participants will be 30 adults with a history of major depressive disorder and current, active depressive symptoms. Following psychiatric and medical safety evaluations, eligible participants will be enrolled in a 12-session CBT that includes classic PAT safety elements (termed psilocybin-assisted CBT; PA-CBT). Following the third and sixth PA-CBT sessions, participants will engage in two psilocybin drug administration sessions (10 and 25\u2009mg, respectively). Participants will provide feedback about the PA-CBT and complete measures of mood symptoms, psychosocial functioning, cognitive schemas, and affective experiences immediately following each drug administration session, at the completion of PA-CBT, and 3 months following treatment completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      The trial will provide preliminary data on the feasibility, safety, acceptability, and psychosocial effects of PA-CBT. Results will inform randomized clinical trials to test the effects of PA-CBT for patients with depression and other mental health conditions, as well as hypotheses concerning mediating mechanisms at the cognitive and affective levels.\n                      <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:uri>\n                      ID: NCT05227612.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/psymed.2023.0018","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T14:04:47Z","timestamp":1694009087000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development"],"prefix":"10.1177","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-120X","authenticated-orcid":false,"given":"Marc J.","family":"Weintraub","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Jeffrey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Grob","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."},{"name":"The Lunquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lindsey","family":"Bergman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."},{"name":"Private Practice, Santa Monica, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziva D.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."},{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Center for Cannabis and Cannabinoids, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Miklowitz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2016.1170135"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1110"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20346"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1943"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211073759"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/2164957X221081113"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.4.417"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2022.102172"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.873279"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.2180"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.05.036"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2015.02.010"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2010.06.007"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13335"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20421"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv076"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01706-y"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2010.03.001"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211073758"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcbs.2019.11.004"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111420188"},{"key":"e_1_3_4_30_2","first-page":"13","article-title":"Psychedelics, mystical experience, and therapeutic efficacy: A systematic review","author":"Ko K","year":"2022","unstructured":"Ko K, , Knight G, , Rucker JJ, et al. Psychedelics, mystical experience, and therapeutic efficacy: A systematic review. Front Psychiatry, 2022; 13.","journal-title":"Front Psychiatry"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","unstructured":"Bonson KR. Hallucinogenic Drugs. In: eLS Food and Drug Administration. John Wiley & Sons: Silver Springs MD; 2012.","DOI":"10.1002\/9780470015902.a0000166.pub2"},{"issue":"3","key":"e_1_3_4_32_2","first-page":"241","article-title":"Human hallucinogen interactions with drugs affecting serotonergic neurotransmission","volume":"7","author":"Strassman RJ.","year":"1992","unstructured":"Strassman RJ. Human hallucinogen interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacol. 1992; 7(3):241\u2013243.","journal-title":"Neuropsychopharmacol"},{"key":"e_1_3_4_33_2","unstructured":"First MB Williams JBW Karg RS Spitzer RL: Structured Clinical Interview for DSM-5 Disorders Clinician Version (SCID-5-CV). American Psychiatric Association: Arlington VA; 2016."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.7.675"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual Of Mental Disorders (DSM-5\u00ae). American Psychiatric Pub: Washington DC; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198410000-00001"},{"key":"e_1_3_4_37_2","first-page":"101","volume-title":"50 Years of LSD: Current status and perspectives of hallucinogens","author":"Dittrich A.","year":"1994","unstructured":"Dittrich A. Psychological aspects of altered states of consciousness of the LSD type: Measurement of their basic dimensions and prediction of individual differences. In: (Pletscher A, , Ladewig D. eds.) 50 Years of LSD: Current status and perspectives of hallucinogens. New York, NY: Parthenon; 1994. pp. 101\u2013118."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1640-6"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10111704"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7894(04)80036-4"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.2164"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674371305800702"},{"key":"e_1_3_4_44_2","unstructured":"Bourzat F Hunter K. Consciousness Medicine: Indigenous Wisdom Entheogens and Expanded States of Consciousness for Healing and Growth. North Atlantic Books: Berkeley CA; 2019."},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00005"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beth.2019.01.002"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_3_4_48_2","first-page":"93","article-title":"Preliminary evidence for the reliability and validity of an abbreviated profile of mood states","volume":"23","author":"Grove JR","year":"1992","unstructured":"Grove JR, , Prapavessis H. Preliminary evidence for the reliability and validity of an abbreviated profile of mood states. Int J Sport Psychol, 1992; 23:93\u2013109.","journal-title":"Int J Sport Psychol"},{"key":"e_1_3_4_49_2","unstructured":"American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders Text Revision. American Psychiatric Association: Washington DC USA; 2000."},{"key":"e_1_3_4_50_2","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville MD: US Department of Heath Education and Welfare Public Health Service Alcohol Drug Abuse and Mental Health Administration. 1976; pp. 217\u2013222."},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291706007355"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOBA.0000007455.08539.94"},{"key":"e_1_3_4_53_2","first-page":"102","volume-title":"Handbook of personality: Theory and research","author":"John OP","year":"1999","unstructured":"John OP, , Srivastava S. The Big Five Trait taxonomy: History, measurement, and theoretical perspectives. In: Handbook of personality: Theory and research (Pervin LA, , John OP, eds.) Guilford Press; 1999; pp. 102\u2013138."},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979351"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1080\/17439760.2018.1484940"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120967878"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115609019"},{"issue":"3","key":"e_1_3_4_59_2","first-page":"260","article-title":"The revised helping alliance questionnaire (HAq-II): Psychometric properties","volume":"5","author":"Luborsky L","year":"1996","unstructured":"Luborsky L, , Barber JP, , Siqueland L, et al. The revised helping alliance questionnaire (HAq-II): Psychometric properties. J Psychother Pract Res, 1996; 5(3):260.","journal-title":"J Psychother Pract Res"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1159\/000517074"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1159\/000457960"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2022.08.007"}],"container-title":["Psychedelic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/psymed.2023.0018","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/psymed.2023.0018","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/psymed.2023.0018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:27:15Z","timestamp":1777685235000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/psymed.2023.0018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.1089\/psymed.2023.0018"],"URL":"https:\/\/doi.org\/10.1089\/psymed.2023.0018","relation":{},"ISSN":["2831-4425","2831-4433"],"issn-type":[{"value":"2831-4425","type":"print"},{"value":"2831-4433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}